These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33211216)

  • 1. Oral itraconazole for epistaxis in hereditary hemorrhagic telangiectasia: a proof of concept study.
    Kroon S; Snijder RJ; Hosman AE; Vorselaars VMM; Disch FJM; Post MC; Mager JJ
    Angiogenesis; 2021 May; 24(2):379-386. PubMed ID: 33211216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
    Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
    JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Timolol in a Novel Intranasal Thermosensitive Gel for Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis: A Randomized Clinical Trial.
    Peterson AM; Lee JJ; Kallogjeri D; Schneider JS; Chakinala MM; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1006-1014. PubMed ID: 32940653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal Efudix reduces epistaxis in hereditary hemorrhagic telangiectasia.
    de Jel DVC; Disch FJM; Kroon S; Mager JJ; Verdam FJ
    Angiogenesis; 2020 Aug; 23(3):271-274. PubMed ID: 32112177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia.
    Thompson KP; Sykes J; Chandakkar P; Marambaud P; Vozoris NT; Marchuk DA; Faughnan ME
    Orphanet J Rare Dis; 2022 Nov; 17(1):405. PubMed ID: 36344987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal topical estrogen in the management of epistaxis in hereditary hemorrhagic telangiectasia.
    Minami K; Haji T
    Acta Otolaryngol; 2016; 136(5):528-31. PubMed ID: 26808464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal bevacizumab injections improve quality of life in HHT patients.
    Steineger J; Geirdal AØ; Osnes T; Heimdal KR; Dheyauldeen S
    Laryngoscope; 2020 May; 130(5):E284-E288. PubMed ID: 31287573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-estrogen therapy for hereditary hemorrhagic telangiectasia - a long-term clinical trial.
    Yaniv E; Preis M; Shevro J; Nageris B; Hadar T
    Rhinology; 2011 Jun; 49(2):214-6. PubMed ID: 21743879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia: Effects on Epistaxis Severity Score and Quality of Life.
    Baysal M; Ümit EG; Kırkızlar HO; Özdöver AC; Demir AM
    Turk J Haematol; 2019 Feb; 36(1):43-47. PubMed ID: 29880465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentraxin 3 level is elevated in hereditary hemorrhagic telangiectasia and reflects the severity of disease-associated epistaxis.
    Steineger J; Ueland T; Aukrust P; Michelsen A; Osnes T; Heimdal K; Dheyauldeen S
    Laryngoscope; 2019 Jan; 129(1):E44-E49. PubMed ID: 30329172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Meta-analysis.
    Hsu YP; Hsu CW; Bai CH; Cheng SW; Chen C
    Otolaryngol Head Neck Surg; 2019 Jan; 160(1):22-35. PubMed ID: 30200816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia.
    Parambil JG; Gossage JR; McCrae KR; Woodard TD; Menon KVN; Timmerman KL; Pederson DP; Sprecher DL; Al-Samkari H
    Angiogenesis; 2022 Feb; 25(1):87-97. PubMed ID: 34292451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial.
    Yaniv E; Preis M; Hadar T; Shvero J; Haddad M
    Laryngoscope; 2009 Feb; 119(2):284-8. PubMed ID: 19160429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIMolol nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT) - Study protocol of the prospective, randomized, double-blind, controlled cross-over TIM-HHT trial.
    Andorfer KEC; Seebauer CT; Koller M; Zeman F; Berneburg M; Fischer R; Vielsmeier V; Bohr C; Kühnel TS
    Clin Hemorheol Microcirc; 2022; 80(3):307-315. PubMed ID: 34864649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia.
    Shovlin CL; Millar CM; Droege F; Kjeldsen A; Manfredi G; Suppressa P; Ugolini S; Coote N; Fialla AD; Geisthoff U; Lenato GM; Mager HJ; Pagella F; Post MC; Sabbà C; Sure U; Torring PM; Dupuis-Girod S; Buscarini E;
    Orphanet J Rare Dis; 2019 Aug; 14(1):210. PubMed ID: 31462308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding.
    Beckman JD; Li Q; Hester ST; Leitner O; Smith KL; Kasthuri RS
    Orphanet J Rare Dis; 2020 Jul; 15(1):185. PubMed ID: 32660636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia.
    Faughnan ME; Gossage JR; Chakinala MM; Oh SP; Kasthuri R; Hughes CCW; McWilliams JP; Parambil JG; Vozoris N; Donaldson J; Paul G; Berry P; Sprecher DL
    Angiogenesis; 2019 Feb; 22(1):145-155. PubMed ID: 30191360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia.
    Parambil JG; Woodard TD; Koc ON
    Laryngoscope; 2018 Oct; 128(10):2234-2236. PubMed ID: 29451965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Beta-Blockers in Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic Review.
    Albarki H; Rimmer J
    Am J Rhinol Allergy; 2022 Nov; 36(6):890-896. PubMed ID: 35929049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.
    Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Ramirez JR; Morales-Angulo C; Zarrabeitia R; Perez-Molino A; Bernabéu C; Botella LM
    Thromb Haemost; 2007 Feb; 97(2):254-62. PubMed ID: 17264955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.